These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5025003)

  • 21. Use of Anovlar in gynaecological disorders and contraception.
    Shahani SM; Chiklikar A
    J Obstet Gynaecol India; 1968 Apr; 18(2):592-7. PubMed ID: 12331827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of the estrogenicity of various synthetic estrogens by means of vaginal hormonocytology].
    Teter J; Krzywdzinski K
    Rev Fr Endocrinol Clin; 1971; 12(1):9-20. PubMed ID: 4944905
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause.
    Le Donne M; Caruso C; Mancuso A; Costa G; Iemmo R; Pizzimenti G; Cavallari V
    Arch Gynecol Obstet; 2011 Jun; 283(6):1319-23. PubMed ID: 20577750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytologic evaluation of hormonal dynamic in the postmenopause.
    Schachter A; Segall A; Avram E; Bahary C
    Maturitas; 1979 Jun; 1(4):269-77. PubMed ID: 551237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
    Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
    Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lasofoxifene enhances vaginal mucus formation without causing hypertrophy and increases estrogen receptor beta and androgen receptor in rats.
    Wang XN; Simmons HA; Salatto CT; Cosgrove PG; Thompson DD
    Menopause; 2006; 13(4):609-20. PubMed ID: 16837883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and cytologic responses of postmenopausal women to estrogen.
    Lin TJ; So-Bosita JL; Brar HK; Roblete BV
    Obstet Gynecol; 1973 Jan; 41(1):97-107. PubMed ID: 4345382
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
    Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
    Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen effects on human oral epithelium. Cytologic, histologic and clinical comparisons.
    Silverman S; Shouse C
    J Oral Ther Pharmacol; 1966 Sep; 3(2):87-93. PubMed ID: 4291773
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical, endocrine, and other indices during quinestrol therapy.
    Danowski TS; Kenny FM; Wilson HR; Sabeh G; Sunder JH; Corredor DG
    Clin Pharmacol Ther; 1970; 11(2):260-8. PubMed ID: 4190444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of tamoxifen on the vaginal epithelium in postmenopausal women.
    Love RR; Kurtycz DF; Dumesic DA; Laube DW; Yang Y
    J Womens Health Gend Based Med; 2000 Jun; 9(5):559-63. PubMed ID: 10883948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone-sparing properties of oral contraceptives.
    DeCherney A
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):15-20. PubMed ID: 8571999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy.
    Cotreau MM; Chennathukuzhi VM; Harris HA; Han L; Dorner AJ; Apseloff G; Varadarajan U; Hatstat E; Zakaria M; Strahs AL; Crabtree JS; Winneker RC; Jelinsky SA
    Maturitas; 2007 Dec; 58(4):366-76. PubMed ID: 17997058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of raloxifene on the vaginal epithelium of postmenopausal women.
    Delmanto A; Nahas-Neto J; Nahas EA; de Oliveira ML; Fernandes CE; Traiman P
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):187-92. PubMed ID: 18400357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the climacteric and sequential mestranol and norethisterone on the cervix and genital tract.
    Paterson ME; Allen J; Jordan JA
    Br J Obstet Gynaecol; 1982 Aug; 89(8):657-64. PubMed ID: 7104258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superficial eosinophilic squamous epithelial cells in vaginal smears from postmenopausal women.
    Højgaard K; Henriksen HM; Højgaard L; Lauritzen JB; Loft A
    Acta Obstet Gynecol Scand; 1982; 61(5):429-31. PubMed ID: 7158309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.